US Stock MarketDetailed Quotes

VYGR Voyager Therapeutics

Watchlist
  • 5.750
  • +0.060+1.05%
Close Dec 20 16:00 ET
  • 5.750
  • 0.0000.00%
Post 16:13 ET
314.10MMarket Cap8.71P/E (TTM)

Voyager Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
433.79%24.63M
509.48%29.58M
-87.03%19.52M
511.16%250.01M
5,910.39%90.06M
-88.77%4.61M
581.60%4.85M
22,769.30%150.48M
9.33%40.91M
-105.52%-1.55M
Operating revenue
433.79%24.63M
509.48%29.58M
-87.03%19.52M
511.16%250.01M
5,910.39%90.06M
-88.77%4.61M
581.60%4.85M
22,769.30%150.48M
9.33%40.91M
-105.52%-1.55M
Cost of revenue
Gross profit
Operating expense
12.57%38.41M
47.31%44.6M
29.36%35.7M
39.51%127.99M
56.42%36M
28.06%34.12M
50.80%30.28M
25.39%27.6M
-17.37%91.74M
2.87%23.01M
Selling and administrative expenses
-1.09%8.17M
22.39%10.15M
-4.66%8.61M
15.63%35.82M
21.04%10.24M
13.01%8.26M
9.83%8.29M
17.87%9.03M
-16.82%30.98M
1.33%8.46M
-General and administrative expense
-1.09%8.17M
22.39%10.15M
-4.66%8.61M
15.63%35.82M
21.04%10.24M
13.01%8.26M
9.83%8.29M
17.87%9.03M
-16.82%30.98M
1.33%8.46M
Research and development costs
16.93%30.24M
56.71%34.45M
45.91%27.09M
51.69%92.17M
77.01%25.76M
33.75%25.86M
75.50%21.99M
29.40%18.57M
-17.65%60.76M
3.79%14.55M
Operating profit
53.30%-13.78M
40.91%-15.03M
-113.17%-16.18M
340.01%122.01M
320.10%54.06M
-304.31%-29.51M
-31.29%-25.43M
675.57%122.88M
30.94%-50.84M
-530.78%-24.56M
Net non-operating interest income expense
33.54%4.58M
49.30%4.89M
161.11%4.87M
554.07%11.72M
223.16%3.15M
529.17%3.43M
1,394.98%3.27M
5,912.90%1.86M
559.49%1.79M
251.79%976K
Non-operating interest income
33.54%4.58M
49.30%4.89M
161.11%4.87M
----
----
529.17%3.43M
1,394.98%3.27M
5,912.90%1.86M
----
----
Total other finance cost
----
----
----
-554.07%-11.72M
----
----
----
----
-559.49%-1.79M
----
Other net income (expense)
200K
566.67%20K
-99.89%3K
0
-95.08%3K
-5.62%2.65M
-103.54%-23K
Other non- operating income (expenses)
--200K
566.67%20K
----
-99.89%3K
--0
----
-95.08%3K
----
-5.62%2.65M
-103.54%-23K
Income before tax
65.48%-9M
54.32%-10.12M
-109.07%-11.32M
388.28%133.74M
342.34%57.22M
-247.97%-26.08M
-16.04%-22.15M
685.15%124.75M
34.84%-46.39M
-513.56%-23.61M
Income tax
124.29%43K
-59.32%24K
-98.01%14K
8,700.00%1.41M
5,037.50%822K
-177K
59K
704K
16K
16K
Net income
65.08%-9.04M
54.34%-10.14M
-109.13%-11.33M
385.14%132.33M
338.70%56.4M
-246.96%-25.9M
-16.35%-22.21M
681.85%124.04M
34.82%-46.41M
-513.84%-23.63M
Net income continuous Operations
65.08%-9.04M
54.34%-10.14M
-109.13%-11.33M
385.14%132.33M
338.70%56.4M
-246.96%-25.9M
-16.35%-22.21M
681.85%124.04M
34.82%-46.41M
-513.84%-23.63M
Minority interest income
Net income attributable to the parent company
65.08%-9.04M
54.34%-10.14M
-109.13%-11.33M
385.14%132.33M
338.70%56.4M
-246.96%-25.9M
-16.35%-22.21M
681.85%124.04M
34.82%-46.41M
-513.84%-23.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
65.08%-9.04M
54.34%-10.14M
-109.13%-11.33M
385.14%132.33M
338.70%56.4M
-246.96%-25.9M
-16.35%-22.21M
681.85%124.04M
34.82%-46.41M
-513.84%-23.63M
Basic earnings per share
72.88%-0.16
64.71%-0.18
-106.56%-0.2
354.55%3.08
301.64%1.23
-228.26%-0.59
-2.00%-0.51
644.64%3.05
35.98%-1.21
-506.67%-0.61
Diluted earnings per share
72.88%-0.16
64.71%-0.18
-106.80%-0.2
345.45%2.97
295.08%1.19
-231.11%-0.59
-2.00%-0.51
625.00%2.94
35.98%-1.21
-506.67%-0.61
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 433.79%24.63M509.48%29.58M-87.03%19.52M511.16%250.01M5,910.39%90.06M-88.77%4.61M581.60%4.85M22,769.30%150.48M9.33%40.91M-105.52%-1.55M
Operating revenue 433.79%24.63M509.48%29.58M-87.03%19.52M511.16%250.01M5,910.39%90.06M-88.77%4.61M581.60%4.85M22,769.30%150.48M9.33%40.91M-105.52%-1.55M
Cost of revenue
Gross profit
Operating expense 12.57%38.41M47.31%44.6M29.36%35.7M39.51%127.99M56.42%36M28.06%34.12M50.80%30.28M25.39%27.6M-17.37%91.74M2.87%23.01M
Selling and administrative expenses -1.09%8.17M22.39%10.15M-4.66%8.61M15.63%35.82M21.04%10.24M13.01%8.26M9.83%8.29M17.87%9.03M-16.82%30.98M1.33%8.46M
-General and administrative expense -1.09%8.17M22.39%10.15M-4.66%8.61M15.63%35.82M21.04%10.24M13.01%8.26M9.83%8.29M17.87%9.03M-16.82%30.98M1.33%8.46M
Research and development costs 16.93%30.24M56.71%34.45M45.91%27.09M51.69%92.17M77.01%25.76M33.75%25.86M75.50%21.99M29.40%18.57M-17.65%60.76M3.79%14.55M
Operating profit 53.30%-13.78M40.91%-15.03M-113.17%-16.18M340.01%122.01M320.10%54.06M-304.31%-29.51M-31.29%-25.43M675.57%122.88M30.94%-50.84M-530.78%-24.56M
Net non-operating interest income expense 33.54%4.58M49.30%4.89M161.11%4.87M554.07%11.72M223.16%3.15M529.17%3.43M1,394.98%3.27M5,912.90%1.86M559.49%1.79M251.79%976K
Non-operating interest income 33.54%4.58M49.30%4.89M161.11%4.87M--------529.17%3.43M1,394.98%3.27M5,912.90%1.86M--------
Total other finance cost -------------554.07%-11.72M-----------------559.49%-1.79M----
Other net income (expense) 200K566.67%20K-99.89%3K0-95.08%3K-5.62%2.65M-103.54%-23K
Other non- operating income (expenses) --200K566.67%20K-----99.89%3K--0-----95.08%3K-----5.62%2.65M-103.54%-23K
Income before tax 65.48%-9M54.32%-10.12M-109.07%-11.32M388.28%133.74M342.34%57.22M-247.97%-26.08M-16.04%-22.15M685.15%124.75M34.84%-46.39M-513.56%-23.61M
Income tax 124.29%43K-59.32%24K-98.01%14K8,700.00%1.41M5,037.50%822K-177K59K704K16K16K
Net income 65.08%-9.04M54.34%-10.14M-109.13%-11.33M385.14%132.33M338.70%56.4M-246.96%-25.9M-16.35%-22.21M681.85%124.04M34.82%-46.41M-513.84%-23.63M
Net income continuous Operations 65.08%-9.04M54.34%-10.14M-109.13%-11.33M385.14%132.33M338.70%56.4M-246.96%-25.9M-16.35%-22.21M681.85%124.04M34.82%-46.41M-513.84%-23.63M
Minority interest income
Net income attributable to the parent company 65.08%-9.04M54.34%-10.14M-109.13%-11.33M385.14%132.33M338.70%56.4M-246.96%-25.9M-16.35%-22.21M681.85%124.04M34.82%-46.41M-513.84%-23.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 65.08%-9.04M54.34%-10.14M-109.13%-11.33M385.14%132.33M338.70%56.4M-246.96%-25.9M-16.35%-22.21M681.85%124.04M34.82%-46.41M-513.84%-23.63M
Basic earnings per share 72.88%-0.1664.71%-0.18-106.56%-0.2354.55%3.08301.64%1.23-228.26%-0.59-2.00%-0.51644.64%3.0535.98%-1.21-506.67%-0.61
Diluted earnings per share 72.88%-0.1664.71%-0.18-106.80%-0.2345.45%2.97295.08%1.19-231.11%-0.59-2.00%-0.51625.00%2.9435.98%-1.21-506.67%-0.61
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List